Attached files

file filename
EX-24.1 - EXHIBIT 24.1 - NAVIDEA BIOPHARMACEUTICALS, INC.navb12312014ex24-1powerofa.htm
EX-32.1 - EXHIBIT 32.1 - NAVIDEA BIOPHARMACEUTICALS, INC.navb12312014ex32-1.htm
EX-31.1 - EXHIBIT 31.1 - NAVIDEA BIOPHARMACEUTICALS, INC.navb12312014ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - NAVIDEA BIOPHARMACEUTICALS, INC.navb12312014ex31-2.htm
EX-23.1 - EXHIBIT 23.1 - NAVIDEA BIOPHARMACEUTICALS, INC.navb12312014ex23-1consent.htm
EX-21.1 - EXHIBIT 21.1 - NAVIDEA BIOPHARMACEUTICALS, INC.navb12312014ex21-1subsidia.htm
EXCEL - IDEA: XBRL DOCUMENT - NAVIDEA BIOPHARMACEUTICALS, INC.Financial_Report.xls
10-K - 10-K - NAVIDEA BIOPHARMACEUTICALS, INC.navb1231201410k.htm


Exhibit 32.2

CERTIFICATION OF PERIODIC FINANCIAL REPORT PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002, 18 U.S.C. SECTION 1350

The undersigned hereby certifies that he is the duly appointed and acting Chief Financial Officer of Navidea Biopharmaceuticals, Inc. (the “Company”) and hereby further certifies as follows:
(1)The periodic report containing financial statements to which this certificate is an exhibit fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the periodic report to which this certificate is an exhibit fairly presents, in all material respects, the financial condition and results of operations of the Company.
In witness whereof, the undersigned has executed and delivered this certificate as of the date set forth opposite his signature below.
March 16, 2015
/s/ Brent L. Larson
 
Brent L. Larson
 
Executive Vice President and Chief Financial Officer